Upon no activation differences were observed, we expanded CAR T cells with IL15 and IL21 because recent studies show that combined expression of IL-15 and IL-21 result in a less differentiated profile and longer survival in repeated exposures to tumor cells (31). The gene discussed is IL21; the disease is neoplasm.